Aktiespot

Perrigo Company plc Aktie

PRGO

After-hours
$10.76-0.29 (-2.62%)
Post-Market:$10.61-0.15 (-1.42%)
Chart wird geladen...
Perrigo Company plc Logo

Perrigo Company plc

Eröffnung10.96
Hoch11.12
Tief10.59
Volumen2.01M
P/EN/A
Marktkapitalisierung1.49B
52-Wochen-Hoch28.44
52-Wochen-Tief9.23
Durchschn. Volumen3.19M
Dividende10.50%
Beta0.54
EPS-12.93

Über Perrigo Company plc Aktie

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Unternehmensinformationen

Börse: NYSE (NYQ)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
The Sharp Building
D02 TY74 Dublin, Ireland
Telefon: + 353 1 709 4000

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
14.00
30.1%
Durchschnittliches Kursziel
16.50
53.3%
Median Kursziel
16.00
48.7%
Höchstes Kursziel
20.00
85.9%

Andere sehen auch: